{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-031266","form_type":"8-K","ticker":"STXS","cik":"0001289340","company_name":"Stereotaxis, Inc.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.482048+00:00","generated_at":"2026-05-31T09:58:34.816126+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Stereotaxis Q2 revenue down 43% to $4.5M; net loss $5.8M; expects H2 revenue >$14M","bullets":["Q2 revenue $4.5M vs $7.9M prior year; system revenue $0.2M due to hospital construction delays.","Net loss $5.8M, adjusted net loss $3.3M; operating loss $6.0M, adjusted $3.5M.","Cash and cash equivalents $15.2M at June 30, 2024, no debt; year-end cash target ~$13M.","CE mark obtained for GenesisX, 510(k) submitted in US; acquisition of Access Point Technologies closed.","Full-year revenue expected approximately equal to prior year; H2 revenue >$14M from stable recurring and Genesis shipments."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-031266","json":"https://secwatch.observer/filing/0001493152-24-031266.json","markdown":"https://secwatch.observer/filing/0001493152-24-031266.md","text":"https://secwatch.observer/filing/0001493152-24-031266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289340/000149315224031266/0001493152-24-031266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289340/000149315224031266/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:58:34.816126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}